TELL ME MORE
ABOUT THIS CLINICAL TRIAL for MIGRAINES in CHILDREN
This is an Double Blind, Placebo Controlled Phase 3 Study of an Investigational Medicine for Migraine Patients Ages 6 – 17 Years.
Clinical Trial for Migraines in Children
Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana
Migraine is one of the most common neurological conditions in pediatrics with a prevalence of approximately 8% in children under 20 years of age. Migraine occurs more frequently in adolescents compared with the younger pediatric age groups. There is a significant increase in migraine incidence in females after puberty. In children and adolescents, headache and migraine can result in missed school days, poorer academic performance and a negative impact on quality of life. There are few treatments approved for the acute treatment of migraine in adolescents, and only 1 treatment approved for children aged 6 to 11 years. Thus, there remains a significant unmet need for the acute treatment of migraine in children and adolescents. This is a double-blind, placebo-controlled, phase 3 study of an investigational medicine for acute migraine in children ages 6 – 17. Patient volunteers will have an option to enter a 52 week long-term open-label extension study. Click here for more information on living with pediatric migraine.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimbursement up to $550 may be available.
Watch a short presentation on Migraines
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ACNE Trifarotene Cream used with and 0ral antibiotic to treat severe acne vulgaris | Evansville | Recruiting | 12+ | $600 | Request Info | |
| ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Owensboro | Recruiting | 6 - 17 | $1150 | Request Info | |
| ADHD A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children | Bowling Green Evansville Owensboro | Coming Soon | 4 - 5 | $400 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 65 | $500 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
| COMMON WARTS Efficacy, Safety and Tolerability Study in Children and Adults with Common Warts | Evansville | Coming Soon | 2+ | $350 | Request Info | |
| COVID-19 Safety and Eficacy Study of a Monoclonal Antibody Therapy for Patients with Mild to Moderate COVID-19 | Evansville Owensboro | Recruiting | 18+ | $3000 | Request Info | |
| DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| ECZEMA An open-label expanded access study in adult and adolescent patients age 12+ with moderate-to-severe Atopic Dermatitis (Eczema) | Evansville | Coming Soon | 12+ | $50 per visit | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| IBS- CONSTIPATION An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Paused | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA Comparison Study | BowlingGreen Evansville Owensboro | Recruiting | Newborns | Variable up to $1700, + formula and diapers | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| INFANT VACCINE Comparison Study between two pneumococcal vaccines | Bowling Green | Coming Soon | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |
| MOLLUSCUM (Water Warts) An efficacy and safety, placebo-controlled study for patients with molluscum contagiosum | BowlingGreen Owensboro Evansville | Recruiting | 6 MO+ (children and adults) | $645 | Request Info | |
| PRURITUS (CHRONIC ITCH) An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis | Owensboro | Coming Soon | 18 - 75 | $600 | Request Info | |
| RHEUMATOID ARTHRITIS (RA) This is a comparison study to evaluate an investigational medicine for Rheumatoid Arthritis in adults with moderately or severely active disease and who have had inadequate response to conventional synthetic or biologic Disease Modifying Anti-rheumatic Drugs (DMARDs). | Evansville | Coming Soon | 18+ | Up to $1750 | Request Info | |